Inventor · disambiguated record
Yoshito Terao
Also filed as: TERAO YOSHITO
9 granted patents·3 pending applications·13 citations·filing 2007–2023
78Inventor score
Files withTAKEDA PHARMACEUTICAL3TAKEDA PHARMACEUTICALS CO3CARDURION PHARMACEUTICALS LLC2ASKA PHARM CO LTD1CHANG EDCON1
Top patents by PatentIndex Score
12 records- 0191US10543212B2Substituted amines for treating cardiac diseasesCARDURION PHARMACEUTICALS LLC·Filed 2018·Granted Jan 28, 2020·10 cites·11 claims
- 0269US8921358B2Apoptosis signal-regulating kinase 1 inhibitorsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Dec 30, 2014·2 cites·32 claims
- 0364US8461163B2Substituted N-(pyrazolo[1,5-a]pyrimidin-5-yl)amides as inhibitors of apoptosis signal-regulating kinase 1CHANG EDCON·Filed 2009·Granted Jun 11, 2013·1 cites·36 claims
- 0463US2025340557A1Pyrimidine derivativeASKA PHARM CO LTD·Filed 2023·Application pending·0 cites
- 0555US11197858B2Substituted amines for treating cardiac diseasesCARDURION PHARMACEUTICALS LLC·Filed 2020·Granted Dec 14, 2021·0 cites·8 claims
- 0655US10968178B2IP6K inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 6, 2021·0 cites·18 claims
- 0752US12091410B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 17, 2024·0 cites·13 claims
- 0851US12071434B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Aug 27, 2024·0 cites·14 claims
- 0946US2010029619A1Fused heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2007·Application pending·0 cites
- 1040US9238639B2Aromatic ring compoundTAKEDA PHARMACEUTICAL·Filed 2013·Granted Jan 19, 2016·0 cites·8 claims
- 1134US2012172351A1Novel fused cyclic compound and use thereofNEGORO NOBUYUKI·Filed 2010·Application pending·0 cites
- 1228US8642770B2Indole derivativeMASADA SHINICHI·Filed 2011·Granted Feb 4, 2014·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Yoshito Terao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →